Combined Therapy With the RANKL Inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin Reduces Bone Lesions and Skeletal Tumor Burden in a Model of Breast Cancer Skeletal Metastasis

Cancer Biology and Therapy - United States
doi 10.4161/cbt.9.7.11266
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

A Cathepsin K Inhibitor Reduces Breast Cancer Induced Osteolysis and Skeletal Tumor Burden

Cancer Research
Cancer ResearchOncology
2007English

RANK, RANKL and OPG Expression in Breast Cancer – Influence on Osseous Metastasis

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2012English

RANKL/RANK: From Bone Loss to the Prevention of Breast Cancer

Open Biology
BiochemistryImmunologyGeneticsMolecular BiologyNeuroscience
2016English

Hypercalcemia in Metastatic Breast Cancer Unrelated to Skeletal Metastasis

CMAJ
Medicine
2015English

Chronic Stress, Sympathetic Activation and Skeletal Metastasis of Breast Cancer Cells

BoneKEy Reports
2015English

Conditional Knockdown of Osteopontin Inhibits Breast Cancer Skeletal Metastasis

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

RANKL/RANK/OPG System Beyond Bone Remodeling: Involvement in Breast Cancer and Clinical Perspectives

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis

Calcified Tissue International
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2018English

Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy